ITI Pharma & Healthcare Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 23-05-2024

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies engaged in Pharma and Healthcare.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty Healthcare Index - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 56.61 14.69 25.16 1.82 7,132.82
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 60.81 16.45 26.25 1.95 3,834.82
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 51.37 15.65 25.35 2.01 2,667.21
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 52.35 16.49 27.30 2.00 2,343.94
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 52.98 14.05 25.73 1.99 2,236.01

Fund Holdings as on 30-April-2024

  • Sun Pharmaceutical Industries Limited

  • Max Healthcare Institute Limited

  • Lupin Limited

  • Dr. Reddy's Laboratories Limited

  • Mankind Pharma Limited

  • Apollo Hospitals Enterprise Limited

  • Suven Pharmaceuticals Limited

  • Divi's Laboratories Limited

  • Zydus Lifesciences Limited

  • Laurus Labs Limited

  • Cipla Limited

  • Syngene International Limited

  • Torrent Pharmaceuticals Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Alembic Pharmaceuticals Limited

  • FDC Limited

  • IPCA Laboratories Limited

  • Piramal Pharma Limited

  • Healthcare Global Enterprises Limited

  • Orchid Pharma Limited

  • Archean Chemical Industries Limited

  • Vijaya Diagnostic Centre Limited

  • Ajanta Pharma Limited

  • Caplin Point Laboratories Limited

  • Jupiter Life Line Hospitals Limited

  • Aurobindo Pharma Limited

  • Rainbow Childrens Medicare Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Sanofi India Limited

  • Vishnu Chemicals Limited

  • Fortis Healthcare Limited

  • Metropolis Healthcare Limited

  • Abbott India Limited

  • Sequent Scientific Limited

  • Astec LifeSciences Limited

  • Shilpa Medicare Limited

  • Gland Pharma Limited

  • Strides Pharma Science Limited

  • Sumitomo Chemical India Limited

  • Sun Pharma Advanced Research Company Limited

  • Net Receivables / (Payables)

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Chemicals

  • Pesticides & Agrochemicals

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About ITI Pharma & Healthcare Fund

Scheme Analysis

ITI Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ITI Mutual Fund. It was launched on 08-Nov-2021 and currently has an AUM of ₹161.86 crore. ITI Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty Healthcare Index - TRI as secondary index.

The NAV of ITI Pharma & Healthcare Fund ended down ₹-0.09(-0.65%)yesterday to ₹13.5442.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The ITI Pharma & Healthcare Fund is managed by Dhimant Shah and Rohan Korde.

Fund House Contact

ITI House, 36, R K Shirodkar Marg, Parel Mumbai - 400 012

022-66214999
mfassist@itiorg.com
www.itiamc.com